Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Medication effectiveness may not be the major reason for accepting cardiovascular preventive medication: A population-based survey

Harmsen, Charlotte, Støvring, Henrik, Jarbøl, Dorte, Nexøe, Jørgen, Gyrd-Hansen, Dorte, Nielsen, Jesper, Edwards, Adrian G. and Kristiansen, Ivar 2012. Medication effectiveness may not be the major reason for accepting cardiovascular preventive medication: A population-based survey. BMC Medical Informatics and Decision Making 12 (1) , pp. 89-96. 10.1186/1472-6947-12-89

[img]
Preview
PDF - Published Version
Download (368kB) | Preview

Abstract

Background: Shared decision-making and patients’ choice of interventions are areas of increasing importance, not least seen in the light of the fact that chronic conditions are increasing, interventions considered important for public health, and still non-acceptance of especially risk-reducing treatments of cardiovascular diseases (CVD) is prevalent. A better understanding of patients’ medication-taking behavior is needed and may be reached by studying the reasons why people accept or decline medication recommendations. The aim of this paper was to identify factors that may influence people’s decisions and reasoning for accepting or declining a cardiovascular preventive medication offer. Methods: From a random sample of 4,000 people aged 40–59 years in a Danish population, 1,169 participants were asked to imagine being at increased risk of cardiovascular disease and being offered a preventive medication. After receiving ‘complete’ information about effectiveness of the medication they were asked whether they would accept medication. Finally, they were asked about reasons for the decision. Results: A total of 725 (67%) of 1,082 participants accepted the medication offer. Even quite large effects of medication (up to 8 percentage points absolute risk reduction) had a smaller impact on acceptance to medication than personal experience with cardiovascular disease. Furthermore, increasing age of the participant and living with a partner were significantly associated with acceptance. Some 45% of the respondents accepting justified their choice as being for health reasons, and they were more likely to be women, live alone, have higher income and higher education levels. Among those who did not accept the medication offer, 56% indicated that they would rather prefer to change lifestyle. Conclusions: Medication effectiveness seems to have a moderate influence on people’s decisions to accept preventive medication, while factors such as personal experience with cardiovascular disease may have an equally strong or stronger influence, indicating that practitioners could do well to carefully identify the reasons for their patients’ treatment decisions.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Subjects: R Medicine > R Medicine (General)
R Medicine > RM Therapeutics. Pharmacology
Uncontrolled Keywords: decision-making, risk assessment, risk communication, preventive health services, primary prevention, cardiovascular disease, health behavior
Additional Information: Pdf uploaded in accordance with publisher's policy at http://www.sherpa.ac.uk/romeo/issn/1472-6947/ (accessed 25/02/2014)
Publisher: Biomed Central Ltd
ISSN: 1472-6947
Date of First Compliant Deposit: 30 March 2016
Last Modified: 04 Jun 2017 04:41
URI: http://orca-mwe.cf.ac.uk/id/eprint/42889

Citation Data

Cited 3 times in Google Scholar. View in Google Scholar

Cited 9 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics